Clinical Utility of Pharmacogene Panel‐Based Testing in Patients Undergoing Percutaneous Coronary Intervention

We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimated in a national sample of IBM MarketScan beneficiari...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Transl Sci
Auteurs principaux: El Rouby, Nihal, Alrwisan, Adel, Langaee, Taimour, Lipori, Gloria, Angiolillo, Dominick J, Franchi, Francesco, Riva, Alberto, Elsey, Amanda, Johnson, Julie A., Cavallari, Larisa H., Winterstein, Almut G.
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2020
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7214641/
https://ncbi.nlm.nih.gov/pubmed/31758664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12729
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires